Market Place
Sourcing Support
GeneCentric secures Series C funding for liquid biopsy platform
18 Jun 2025 //
BUSINESSWIRE
GeneCentric Therapeutics Launches EXpressCT Liquid Biopsy Platform
28 Oct 2024 //
BUSINESSWIRE
GeneCentric Publishes Garner Study Results In Bladder Cancer
01 Oct 2024 //
BUSINESSWIRE
GeneCentric Gets PLA Code For PurIST Pancreatic Cancer Test
24 Jul 2024 //
BUSINESSWIRE
GeneCentric To Present At ASCO 2024 Annual Meeting
20 May 2024 //
BUSINESSWIRE
GeneCentric Announces Upcoming Presentations at the Annual Meeting 2024
01 Apr 2024 //
BUSINESSWIRE
GeneCentric Announces Presentations at the American Society of Clinical Oncology
22 Jan 2024 //
BUSINESSWIRE
GeneCentric Therapeutics Appoints Prasanth Reddy and Don Hardison to the Board
14 Nov 2023 //
BUSINESSWIRE
GeneCentric Announces Publication of Results Showing Benefit of RNA-based AF-PRS
20 Jul 2023 //
BUSINESSWIRE
GeneCentric Therapeutics Announces Commercial Availability of PurIST? Test
31 May 2023 //
BUSINESSWIRE
GeneCentric Therapeutics Initiates the Alamance Study
16 May 2023 //
BUSINESSWIRE
GeneCentric Therapeutics Appoints Brian Kelly as SVP Business Development
12 Apr 2023 //
BUSINESSWIRE
GeneCentric to Present Data on the PurIST Test at AACR Pancreatic Conference
13 Sep 2022 //
BUSINESSWIRE
GeneCentric Publishes Data Comparing Predictive Immune Response Profiles
23 Aug 2022 //
BUSINESSWIRE
GeneCentric to Present Initial Clinicogenomic Results from the GARNER Study
10 May 2022 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.